Vigil Neuroscience, Inc. (VIGL)
NASDAQ: VIGL · Real-Time Price · USD
2.960
-0.090 (-2.95%)
Nov 21, 2024, 11:12 AM EST - Market open
Vigil Neuroscience Market Cap
Vigil Neuroscience has a market cap or net worth of $117.36 million as of November 21, 2024. Its market cap has decreased by -52.24% in one year.
Market Cap
117.36M
Enterprise Value
22.83M
1-Year Change
-52.24%
Ranking
Category
Stock Price
$2.96
Market Cap Chart
Since the IPO on January 7, 2022, Vigil Neuroscience's market cap has decreased from $395.70M to $117.36M, a decrease of -70.34%. That is a compound annual growth rate of -34.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 120.53M | -0.61% |
| Dec 29, 2023 | 121.27M | -72.73% |
| Dec 30, 2022 | 444.76M | 12.40% |
| Jan 7, 2022 | 395.70M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Context Therapeutics | 123.75M |
| Outlook Therapeutics | 123.72M |
| Zomedica | 123.47M |
| Repare Therapeutics | 122.43M |
| Alto Neuroscience | 120.83M |
| Protalix BioTherapeutics | 119.87M |
| American Well | 119.33M |
| Fennec Pharmaceuticals | 117.27M |